Clinical Trial Update: Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial assessing dual antiplatelet therapy in shock-complicated acute myocardial infarction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Myocardial Infarction

Drugs mentioned

• Dual antiplatelet therapy (aspirin + P2Y12 inhibitor)

Snippet

Sponsor: Faculty Hospital Kralovske Vinohrady | Conditions: Acute Myocardial Infarction, Cardiogenic Shock | Phase 4 | Status: COMPLETED